AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31

Authors: Kiyoi, H Naoe, T
Citation: H. Kiyoi et T. Naoe, Immunoglobulin variable region structure and B-cell malignancies, INT J HEMAT, 73(1), 2001, pp. 47-53

Authors: Hanamura, I Iida, S Akano, Y Hayami, Y Kato, M Miura, K Harada, S Banno, S Wakita, A Kiyoi, H Naoe, T Shimizu, S Sonta, S Nitta, M Taniwaki, M Ueda, R
Citation: I. Hanamura et al., Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations, JPN J CANC, 92(6), 2001, pp. 638-644

Authors: Kosugi, H Ito, M Yamamoto, Y Towatari, M Ito, M Ueda, R Saito, H Naoe, T
Citation: H. Kosugi et al., In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD/Shi-scid/scid mice, JPN J CANC, 92(5), 2001, pp. 529-536

Authors: Kunishima, S Naoe, T Kamiya, T Saito, H
Citation: S. Kunishima et al., Novel heterozygous missense mutation in the platelet glycoprotein Ib beta gene associated with isolated giant platelet disorder, AM J HEMAT, 68(4), 2001, pp. 249-255

Authors: Naoe, T Kiyoi, H Yamamoto, Y Minami, Y Yamamoto, K Ueda, R Saito, H
Citation: T. Naoe et al., FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy, CANC CHEMOT, 48, 2001, pp. S27-S30

Authors: Hirose, Y Kiyoi, H Itoh, K Kato, K Saito, H Naoe, T
Citation: Y. Hirose et al., B-cell precursors differentiated from cord blood CD34(+) cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34(+) cells, IMMUNOLOGY, 104(4), 2001, pp. 410-417

Authors: Yamamoto, Y Kiyoi, H Nakano, Y Suzuki, R Kodera, Y Miyawaki, S Asou, N Kuriyama, K Yagasaki, F Shimazaki, C Akiyama, H Saito, K Nishimura, M Motoji, T Shinagawa, K Takeshita, A Saito, H Ueda, R Ohno, R Naoe, T
Citation: Y. Yamamoto et al., Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies, BLOOD, 97(8), 2001, pp. 2434-2439

Authors: Naoe, T Takeyama, K Yokozawa, T Kiyoi, H Seto, M Uike, N Ino, T Utsunomiya, A Maruta, A Jin-Nai, I Kamada, N Kubota, Y Nakamura, H Shimazaki, C Horiike, S Kodera, Y Saito, H Ueda, R Wiemels, J Ohno, R
Citation: T. Naoe et al., Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related Leukemia/Myelodysplastic Syndrome and de novo acute myeloid leukemia, CLIN CANC R, 6(10), 2000, pp. 4091-4095

Authors: Naoe, T Nakano, Y Kiyoi, H
Citation: T. Naoe et al., Leukemia relapse reconsidered from the molecular aspect, LEUK LYMPH, 37(5-6), 2000, pp. 527-534

Authors: Hayakawa, F Towatari, M Kiyoi, H Tanimoto, M Kitamura, T Saito, H Naoe, T
Citation: F. Hayakawa et al., Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines, ONCOGENE, 19(5), 2000, pp. 624-631

Authors: Murata, M Towatari, M Kosugi, H Tanimoto, M Ueda, R Saito, H Naoe, T
Citation: M. Murata et al., Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells, JPN J CANC, 91(11), 2000, pp. 1154-1160

Authors: Nakano, Y Naoe, T Kiyoi, H Kitamura, K Minami, S Miyawaki, S Asou, N Kuriyama, K Kusumoto, S Shimazaki, C Akiyama, H Saito, K Nishimura, M Motoji, T Shinagawa, K Saito, H Ohno, R
Citation: Y. Nakano et al., Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia, EUR J HAEMA, 65(1), 2000, pp. 23-31

Authors: Zhao, M Kiyoi, H Yamamoto, Y Ito, M Towatari, M Omura, S Kitamura, T Ueda, R Saito, H Naoe, T
Citation: M. Zhao et al., In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor, LEUKEMIA, 14(3), 2000, pp. 374-378

Authors: Kitamura, K Minami, Y Yamamoto, K Akao, Y Kiyoi, H Saito, H Naoe, T
Citation: K. Kitamura et al., Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis, LEUKEMIA, 14(10), 2000, pp. 1743-1750

Authors: Yokozawa, T Towatari, M Iida, H Takeyama, K Tanimoto, M Kiyoi, H Motoji, T Asou, N Saito, K Takeuchi, M Kobayashi, Y Miyawaki, S Kodera, Y Ohno, R Saito, H Naoe, T
Citation: T. Yokozawa et al., Prognostic significance of the cell cycle inhibitor p27(Kip1) in acute myeloid leukemia, LEUKEMIA, 14(1), 2000, pp. 28-33

Authors: Mason, R Nakase, N Naoe, T
Citation: R. Mason et al., Craft education in lower secondary schools in England and Japan: a comparative study, COMP EDUC, 36(4), 2000, pp. 397-416

Authors: Kitagawa, N Goto, M Kurozumi, K Maruo, S Fukayama, M Naoe, T Yasukawa, M Hino, K Suzuki, T Todo, S Takada, K
Citation: N. Kitagawa et al., Epstein-Barr virus-encoded poly(A)- RNA supports Burkitt's lymphoma growththrough interleukin-10 induction, EMBO J, 19(24), 2000, pp. 6742-6750

Authors: Nakano, Y Naoe, T Kiyoi, H Kunishima, S Minami, S Miyawaki, S Asou, N Kuriyama, K Saito, H Ohno, R
Citation: Y. Nakano et al., Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia, LEUK RES, 24(4), 2000, pp. 349-352

Authors: Kitamura, K Hoshi, S Koike, M Kiyoi, H Saito, H Naoe, T
Citation: K. Kitamura et al., Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid, BR J HAEM, 108(4), 2000, pp. 696-702

Authors: Takeshita, A Shinjo, K Naito, K Ohnishi, K Sugimoto, Y Yamakawa, Y Tanimoto, M Kitamura, K Naoe, T Ouno, R
Citation: A. Takeshita et al., Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA, BR J HAEM, 108(1), 2000, pp. 90-92

Authors: Yoshida, M Tsubaki, K Kobayashi, T Tanimoto, M Kuriyama, K Murakami, H Minami, S Hiraoka, A Takahashi, I Naoe, T Asou, N Kageyama, S Tomonaga, M Saito, H Ohno, R
Citation: M. Yoshida et al., Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991, INT J HEMAT, 70(4), 1999, pp. 261-267

Authors: Miyawaki, S Kobayashi, T Tanimoto, M Kuriyama, K Murakami, H Yoshida, M Minami, S Minato, K Tsubaki, K Omoto, E Oh, H Jinnai, I Sakamaki, H Hiraoka, A Kanamura, A Takahashi, I Saito, K Naoe, T Yamada, O Asou, N Kageyama, S Emi, N Ueda, T Tomonaga, M Saito, H Ueda, R Ohno, R
Citation: S. Miyawaki et al., Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy, INT J HEMAT, 70(1), 1999, pp. 56-57

Authors: Kosugi, H Towatari, M Hatano, S Kitamura, K Kiyoi, H Kinoshita, T Tanimoto, M Murate, T Kawashima, K Saito, H Naoe, T
Citation: H. Kosugi et al., Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy, LEUKEMIA, 13(9), 1999, pp. 1316-1324

Authors: Kiyoi, H Naoe, T
Citation: H. Kiyoi et T. Naoe, Reply - Review of the immunoglobulin light chain variable region sequencesfrom multiple myeloma cells, LEUKEMIA, 13(5), 1999, pp. 829-830

Authors: Yanagi, M Shinjo, K Takeshita, A Tobita, T Yano, K Kobayashi, M Terasaki, H Naoe, T Ohnishi, K Ohno, R
Citation: M. Yanagi et al., Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells, LEUKEMIA, 13(4), 1999, pp. 542-552
Risultati: 1-25 | 26-31